Efficacy and the Safety of Flumatinib in Treatment of CML-CP Patients With Ph+ Post Imatinib Failure
Latest Information Update: 06 Mar 2024
At a glance
- Drugs Flumbatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 16 Jan 2021 Status changed from not yet recruiting to recruiting.
- 24 Dec 2020 New trial record